Cystic fibrosis secondary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(2 intermediate revisions by one other user not shown)
Line 4: Line 4:


==Overview==
==Overview==
In cystic fibrosis secondary prevention include airway clearance techniques, dornase alpha, hypertonic saline, antibiotics, immunizations, physical activity, nutritional support for pancreatic insufficiency and extra salt and water.
Effective measures for secondary prevention of cystic fibrosis include [[airway]] clearance techniques, [[Dornase alfa|dornase alpha]], [[hypertonic]] [[Saline (medicine)|saline]], [[Antibiotic|antibiotics]], [[Vaccination|immunizations]], [[Physical exercise|physical activity]], nutritional support for [[pancreatic insufficiency]] and extra salt and water.


==Secondary Prevention==
==Secondary Prevention==
In cystic fibrosis secondary prevention include:<ref name="pmid29303286">{{cite journal |vauthors=Fila L |title=[Cystic fibrosis in adults] |language=Czech |journal=Vnitr Lek |volume=63 |issue=11 |pages=834–842 |date= 2018 |pmid=29303286 |doi= |url=}}</ref><ref name="urlCystic Fibrosis and Congenital Absence of the Vas Deferens - GeneReviews® - NCBI Bookshelf">{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK1250/ |title=Cystic Fibrosis and Congenital Absence of the Vas Deferens - GeneReviews® - NCBI Bookshelf |format= |work= |accessdate=}}</ref>
Effective measures for secondary prevention of cystic fibrosis include:<ref name="pmid29303286">{{cite journal |vauthors=Fila L |title=[Cystic fibrosis in adults] |language=Czech |journal=Vnitr Lek |volume=63 |issue=11 |pages=834–842 |date= 2018 |pmid=29303286 |doi= |url=}}</ref><ref name="urlCystic Fibrosis and Congenital Absence of the Vas Deferens - GeneReviews® - NCBI Bookshelf">{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK1250/ |title=Cystic Fibrosis and Congenital Absence of the Vas Deferens - GeneReviews® - NCBI Bookshelf |format= |work= |accessdate=}}</ref>
* Airway clearance techniques
* [[Airway]] clearance techniques
* Dornase alpha
* [[Dornase alfa|Dornase alpha]]
* Hypertonic saline
* [[Hypertonic]] [[Saline (medicine)|saline]]
* Antibiotics for prevention of airway [[infection]] with resistant bacterial pathogens (especially ''[[Pseudomonas aeruginosa|P. aeruginosa]]'')
* [[Antibiotic|Antibiotics]] for prevention of [[airway]] [[infection]] with resistant [[Bacteria|bacterial]] [[Pathogen|pathogens]] (especially ''[[Pseudomonas aeruginosa|P. aeruginosa]]'')
* Immunizations including anti-RSV monoclonal antibody
* [[Vaccination|Immunizations]] including anti-RSV [[Monoclonal antibodies|monoclonal antibody]]
* Physical activity to maintain bone health and improve airway clearance
* [[Physical exercise|Physical activity]] to maintain bone health and improve [[airway]] clearance
* Nutritional support for pancreatic insufficiency
* Nutritional support for [[pancreatic insufficiency]]
* Extra salt and water
* Extra salt and water
* Hot and dry climates
* Hot and dry climates
Line 23: Line 23:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category: (name of the system)]]
 
[[Category:Medicine]]
[[Category:Up-To-Date]]
[[Category:Gastroenterology]]
[[Category:Pediatrics]]
[[Category:Pulmonology]]

Latest revision as of 20:30, 29 March 2018

Cystic fibrosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cystic fibrosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography or Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cystic fibrosis secondary prevention On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cystic fibrosis secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cystic fibrosis secondary prevention

CDC on Cystic fibrosis secondary prevention

Cystic fibrosis secondary prevention in the news

Blogs on Cystic fibrosis secondary prevention

Directions to Hospitals Treating Cystic fibrosis

Risk calculators and risk factors for Cystic fibrosis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]

Overview

Effective measures for secondary prevention of cystic fibrosis include airway clearance techniques, dornase alpha, hypertonic saline, antibiotics, immunizations, physical activity, nutritional support for pancreatic insufficiency and extra salt and water.

Secondary Prevention

Effective measures for secondary prevention of cystic fibrosis include:[1][2]

References

  1. Fila L (2018). "[Cystic fibrosis in adults]". Vnitr Lek (in Czech). 63 (11): 834–842. PMID 29303286.
  2. "Cystic Fibrosis and Congenital Absence of the Vas Deferens - GeneReviews® - NCBI Bookshelf".

Template:WH Template:WS